The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Sangamo BioSciences Inc

Nasdaq: SGMO
Last

(U.S.) $6.30

Today's change0.00 0.00%
Updated April 29 4:00 PM EDT. Delayed by at least 15 minutes.
 

Sangamo BioSciences Inc

Nasdaq: SGMO
Last

(U.S.) $6.30

Today's change0.00 0.00%
Updated April 29 4:00 PM EDT. Delayed by at least 15 minutes.

Sangamo BioSciences Inc down slightly

Sangamo BioSciences Inc closed down just (U.S.)$0.00 Friday to (U.S.)$6.30. Over the last five days, shares have lost 11.52% and are down 31.00% for the last year to date. This security has underperformed the S&P 500 by 49.42% during the last year.

Key company metrics

  • Open(U.S.) $6.30
  • Previous close(U.S.) $6.30
  • High(U.S.) $6.45
  • Low(U.S.) $6.14
  • Bid / Ask(U.S.) $4.19 / (U.S.) $6.60
  • YTD % change-31.00%
  • Volume809,798
  • Average volume (10-day)650,578
  • Average volume (1-month)844,697
  • Average volume (3-month)1,051,951
  • 52-week range(U.S.) $4.63 to (U.S.) $13.57
  • Beta2.26
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.58
Updated April 29 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.47%Sector:HealthcareIndustry:Biotechnology

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue99813
Total other revenue--------
Total revenue99813
Gross profit--------
Total cost of revenue--------
Total operating expense25212120
Selling / general / administrative5555
Research & development20171615
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-16-13-12-6
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-16-13-12-6
Income after tax-14-9-12-5
Income tax, total-2-30-1
Net income-14-9-12-5
Total adjustments to net income--------
Net income before extra. items-14-9-12-5
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-14-9-12-5
Inc. avail. to common incl. extra. items-14-9-12-5
Diluted net income-14-9-12-5
Dilution adjustment--------
Diluted weighted average shares70707069
Diluted EPS excluding extraordinary itemsvalue per share-0.20-0.13-0.17-0.08
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share-0.20-0.13-0.17-0.08